July/August 2021

Feature

Research Reports

Treatment and Outcomes Among Hospitalized COVID-19 Patients With Immune-mediated Inflammatory Diseases: An Electronic Health Record Database Cohort Study

08/20/2021

Alex Z Fu, PhD

Qian Cai, MSPH, MS

Emily S Brouwer, MPH, PharmD PhD

Christopher D Pericone, PhD

Kimberly Woodruff, PharmD, PhD

Alex Z Fu, PhD, and colleagues explore treatment journeys and outcomes for hospitalized COVID-19 patients with rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn's disease, or ulcerative colitis.

Alex Z Fu, PhD, and colleagues...

08/20/2021

Journal of Clinical Pathways

From the Field

Anticipated Cost Savings with Alternate Dosing Schema of Nivolumab/Ipilimumab for the Treatment of Metastatic Melanoma

08/20/2021

Allison Kupsh, PharmD

Laura Alwan, PharmD

Eve Segal, PharmD

Kate Trieselmann, PharmD

Evan Hall, MD

Allison Kupsh, PharmD, and colleagues found that the anticipated cost of NIVO3+IPI1 for the treatment of metastatic melanoma may be lower compared when compared with NIVO1+IPI3, amounting to over $1,000,000 in total savings.

Allison Kupsh, PharmD, and...

08/20/2021

Journal of Clinical Pathways

Column

Editor's Page

Catching Up After Summer Break

08/20/2021

Winston Wong, PharmD

Winston Wong, PharmD, discusses the articles in this issue, which include research examining the impact of a SARS-CoV-2 infection on patients previously diagnosed with immune-mediated inflammatory diseases, and results from a study examining...

Winston Wong, PharmD, discusses...

08/20/2021

Journal of Clinical Pathways

COA Viewpoint

SCOTUS Upholds Limits on Pharmacy Benefits Managers

08/19/2021

Ricky Newton, CPA, chief financial & operating officer, Community Oncology Alliance

Ricky Newton, CPA, weighs in on states seeking to enact legislation regulating pharmacy benefit managers, which he describes as the "next frontier" in the ongoing war with the pharmacy benefit managers.

Ricky Newton, CPA, weighs in on...

08/19/2021

Journal of Clinical Pathways

Clinical Pathways GPS

Clinical Pathways Improving Management of Rare Conditions

08/19/2021

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.

Richard Stefanacci, DO, MGH,...

08/19/2021

Journal of Clinical Pathways

Pharma Insights

The Complementary Relationship Between Quantitative and Qualitative Research Methods in Enhancing Understanding of Treatment Decisions, Outcomes, and Value Assessment

08/19/2021

Marlon Graf, PhD

Rifat Tuly, MPH

Suepattra G May, MPH, PhD

Marlon Graf, PhD, and colleagues discuss how evidence generated through a mix of both quantitative and qualitative research methods are necessary in addressing complexity in healthcare innovation and care delivery.

Marlon Graf, PhD, and colleagues...

08/19/2021

Journal of Clinical Pathways

Trending From ACCC

Geriatric Assessment is Critical for Treating Older Adults with Cancer

08/19/2021

Association of Community Cancer Centers

The Association of Community Cancer Centers discuss how conducting a geriatric assessment can help uncover the comorbidities and age-related vulnerabilities that can impact cancer treatment in older adults.

The Association of Community...

08/19/2021

Journal of Clinical Pathways

Department

Clinical Pathways Forum

Internally Developed Clinical Pathways in an Integrated Health System

08/19/2021

Mishellene McKinney, MHA, RN, OCN

Mishellene McKinney, MHA, RN, OCN discusses how Kaiser Permanente's Excellence in Cancer Care program uses clinical pathways to take an enterprise approach to care while considering the unique capabilities and demographics and autonomy of...

Mishellene McKinney, MHA, RN,...

08/19/2021

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

July/August 2021

Feature

Column

Department

Current Issue

Special Reports

Subscribe

August 2021 Volume 7 Issue 6

Specialties

Events

Year Round Education

HMP Global Products